Skip to main content
1D

Earnings preview · NOVO-B.CO

Novo Nordisk earnings preview (November 4): what analysts expect

Novo Nordisk A/S reports its Jul-Sep 2026 quarter on Wednesday, November 4. Here is what the market expects and how it gets there, in charts.

InbestPlanners · Updated Oct 30, 2026 · 3 min read

Nov4

Wednesday, November 4

Results day · call at 1:00 PM Madrid time · confirmed date

In 30 seconds

  • Expected earnings per share: DKK 4.89 (+8.8% on the same quarter a year ago).
  • Expected sales: DKK 73.7B (-1.7% year on year).
  • It beat the earnings estimate in 3 of its last 4 quarters.
  • The share arrives down 12.1% over three months and down 13.6% over a year.

Expected EPS

DKK 4.89

+8.8% vs. a year ago

Expected sales

DKK 73.7B

-1.7% y/y

Beat estimates

3 / 4

last quarters

Share, 12 months

-13.6%

Close DKK 266.10

Earnings per share: expected against reported

Every quarter analysts publish how much they think Novo Nordisk will earn per share. The grey bar is their estimate; the coloured one, what the company reported. On the right, what they expect now (9 analysts), with the lowest and highest estimate.

4.90
4.50

Jul-Sep
2025

Miss

5.78
6.04

Oct-Dec
2025

Beat

5.41
6.63

Jan-Mar
2026

Beat

5.04
6.18

Apr-Jun
2026

Beat

4.89

Jul-Sep
2026

Now

Expected Reported Now (low-high estimates: 4.60 - 5.34)

In the last 4 quarters it beat the estimate 3 times. On average, reported earnings came in 10.4% above the estimate.

Sales and margins

Sales each quarter, in billions of DKK; the dotted bar is what is expected now: DKK 73.7B, against DKK 75.0B a year earlier.

76.9

Apr-Jun
2025

75.0

Jul-Sep
2025

79.1

Oct-Dec
2025

96.8

Jan-Mar
2026

78.5

Apr-Jun
2026

73.7

Jul-Sep
2026

QuarterGross marginOperating marginNet income
Apr-Jun 202583.3%43.5%DKK 26.5B
Jul-Sep 202576.1%31.6%DKK 20.0B
Oct-Dec 202580.9%40.1%DKK 26.9B
Jan-Mar 202686.0%61.6%DKK 48.6B
Apr-Jun 202678.2%34.5%DKK 21.0B

How Novo Nordisk shares arrive

DKK 266.10

Close of Oct 30, 2026 · last year

High DKK 383.09Low DKK 220.97
Oct 2025Oct 2026

1 month

+5.1%

3 months

-12.1%

YTD

-14.3%

12 months

-13.6%

Over the last year it traded between DKK 220.97 and DKK 383.09. It trades at 10 times the last twelve months' earnings and 12 times next year's expected earnings (P/E).

What to watch on November 4

  1. 01

    Earnings per share

    The benchmark is DKK 4.89. Above it, the market reads "beat".

  2. 02

    Sales

    DKK 73.7B expected. Profit can beat through cuts; sales tell whether the business grows.

  3. 03

    Gross margin

    Last quarter it was 78.2%. If it falls, it sells cheaper or produces at a higher cost.

Frequently asked questions

When does Novo Nordisk report earnings?

Novo Nordisk reports its Jul-Sep 2026 quarter on Wednesday, November 4. The analyst call is at 1:00 PM Madrid time.

What EPS do analysts expect from Novo Nordisk?

The consensus of 9 analysts is DKK 4.89 per share, with estimates from DKK 4.60 to DKK 5.34. A year ago it was DKK 4.50.

What sales are expected from Novo Nordisk?

Analysts expect sales of DKK 73.7B, against DKK 75.0B a year ago.

Does Novo Nordisk usually beat estimates?

In the last 4 quarters it beat the EPS estimate 3 times; on average reported earnings came in 10.4% above the estimate. Having done it before says nothing about this time.

All earnings previews

Information, not investment advice. Figures are the data provider's (analyst consensus and accounts published by Novo Nordisk A/S) as of Oct 30, 2026; EPS is the one analysts compare and may differ from reported GAAP figures. Quarters are calendar quarters (Jul-Sep 2026), whatever the company's fiscal numbering. Past performance does not guarantee future results.